Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals.

Bækvad-Hansen M, Nordestgaard BG, Dahl M.

Eur Respir J. 2011 Apr;37(4):791-9. doi: 10.1183/09031936.00026410. Epub 2010 Aug 6.

2.

Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function, and chronic obstructive pulmonary disease in smokers.

Baekvad-Hansen M, Dahl M, Tybjaerg-Hansen A, Nordestgaard BG.

Am J Respir Crit Care Med. 2010 Jan 1;181(1):17-20. doi: 10.1164/rccm.200906-0963OC. Epub 2009 Oct 15.

PMID:
19833825
3.

β2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies.

Thomsen M, Nordestgaard BG, Sethi AA, Tybjærg-Hansen A, Dahl M.

Eur Respir J. 2012 Mar;39(3):558-66. doi: 10.1183/09031936.00023511. Epub 2011 Nov 10.

4.

CHRNA3 genotype, nicotine dependence, lung function and disease in the general population.

Kaur-Knudsen D, Nordestgaard BG, Bojesen SE.

Eur Respir J. 2012 Dec;40(6):1538-44. doi: 10.1183/09031936.00176811. Epub 2012 Mar 22.

5.

EPHX1 polymorphisms, COPD and asthma in 47,000 individuals and in meta-analysis.

Lee J, Nordestgaard BG, Dahl M.

Eur Respir J. 2011 Jan;37(1):18-25. doi: 10.1183/09031936.00012110. Epub 2010 Jun 1.

6.

Relationship between the microsatellite D2S388-5 and D2S2232 polymorphisms and chronic obstructive pulmonary disease in the Chinese Kazakh population.

Guan J, Liu XS, Xu YJ, Xu XL, Yang YS, Wang R.

Respirology. 2013 Feb;18(2):303-7. doi: 10.1111/resp.12000.

PMID:
23088317
7.

Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population.

Guo X, Lin HM, Lin Z, Montaño M, Sansores R, Wang G, DiAngelo S, Pardo A, Selman M, Floros J.

Eur Respir J. 2001 Sep;18(3):482-90.

8.

Lower FEV1 in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV1, total IgE levels, and TSLP genotypes.

Masuko H, Sakamoto T, Kaneko Y, Iijima H, Naito T, Noguchi E, Hirota T, Tamari M, Hizawa N.

Int J Chron Obstruct Pulmon Dis. 2011;6:181-9. doi: 10.2147/COPD.S16383. Epub 2011 Mar 2.

9.

Association of surfactant protein B gene with chronic obstructive pulmonary disease susceptibility.

Yang J, Wang B, Zhou HX, Liang BM, Chen H, Ma CL, Xiao J, Deng J, Yan L, Chen YP, Chen CL, Chen F, Ou XM, Feng YL.

Int J Tuberc Lung Dis. 2014 Nov;18(11):1378-84. doi: 10.5588/ijtld.13.0569.

PMID:
25299874
10.
12.

Adam33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers.

Sadeghnejad A, Ohar JA, Zheng SL, Sterling DA, Hawkins GA, Meyers DA, Bleecker ER.

Respir Res. 2009 Mar 12;10:21. doi: 10.1186/1465-9921-10-21.

13.

CHRNA3 and CYP3A5*3 genotype, lung function and chronic obstructive pulmonary disease in the general population.

Kaur-Knudsen D, Bojesen SE, Nordestgaard BG.

Pharmacogenet Genomics. 2014 Apr;24(4):220-9. doi: 10.1097/FPC.0000000000000038.

PMID:
24535486
14.

Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease.

Juul K, Tybjaerg-Hansen A, Marklund S, Lange P, Nordestgaard BG.

Am J Respir Crit Care Med. 2006 Apr 15;173(8):858-64. Epub 2006 Jan 6.

PMID:
16399992
15.

Two novel mutations in surfactant protein-C, lung function and obstructive lung disease.

Baekvad-Hansen M, Nordestgaard BG, Tybjaerg-Hansen A, Dahl M.

Respir Med. 2010 Mar;104(3):418-25. doi: 10.1016/j.rmed.2009.10.012. Epub 2009 Nov 11.

16.

Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking.

Kobayashi H, Kanoh S, Motoyoshi K.

Biomarkers. 2008 Jun;13(4):385-92. doi: 10.1080/13547500801903651 .

PMID:
18595202
17.

Genetic and biochemical markers of obstructive lung disease in the general population.

Dahl M.

Clin Respir J. 2009 Apr;3(2):121-2. doi: 10.1111/j.1752-699X.2008.00110.x.

PMID:
20298391
18.

Genetic polymorphisms in the surfactant proteins in systemic sclerosis in Japanese: T/T genotype at 1580 C/T (Thr131Ile) in the SP-B gene reduces the risk of interstitial lung disease.

Sumita Y, Sugiura T, Kawaguchi Y, Baba S, Soejima M, Murakawa Y, Hara M, Kamatani N.

Rheumatology (Oxford). 2008 Mar;47(3):289-91. doi: 10.1093/rheumatology/kem355. Epub 2008 Feb 8.

PMID:
18263595
19.

Relationship of vitamin D binding protein polymorphisms and lung function in Korean chronic obstructive pulmonary disease.

Jung JY, Choi DP, Won S, Lee Y, Shin JH, Kim YS, Kim SK, Oh YM, Suh I, Lee SD.

Yonsei Med J. 2014 Sep;55(5):1318-25. doi: 10.3349/ymj.2014.55.5.1318.

20.

Supplemental Content

Support Center